DDMAC's Abrams Promises ‘Careful' Review of Presentations
Tom Abrams promised a careful review of the presentations and data as the FDA's two-day hearing on online promotion and social media came to a close Nov. 13 in Washington... (read more)
Eli Lilly Looking For More ‘Clarity' From FDA
In the current environment, Lilly has decided to avoid “significant interaction” via social media with patients and healthcare professionals “largely because..." (read more)
Lack of Clarity for Online Ads Creates Confusion
Yahoo! believes that allowing the brand information to be available in a search result would allow for greater clarity and transparency...[Yahoo!] is also experimenting with other models to better communicate with consumers... (read more)
Consumers Want, Expect Pharma To Participate in Social Media
Using a proprietary digital anthropology tool and a 300 patient online survey, Rapp researched to understand what consumers expect and whom they hold accountable... results indicate that consumers do view the various media platforms... (read more)
Consumers Seek Health, Safety Information Through Online and Social Media Channels
In preparation for the FDA hearings [on social media]...Euro RSCG Life 4D conducted new research leveraging various social media tools and resources... survey was deployed to more than 1,700 social media users... (read more)
comScore Survey: 50% of Health-Info Seekers Use Social Media to Find Health Information
“Pharma sites educate sufferers about treatments and side effects, but when you are looking at learning about a condition, it really is something that the content sites are really sought after for,” explained John Mangano of comScore... (read more)
‘One-Click' Rule Is Not Good Regulatory Policy
Speaking on the opening day of the hearings, Zuckerman acknowledged that companies face higher costs to include additional fair balance in TV, radio and print ads. “That isn't true for the Internet..." (read more)